{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:24:59Z","timestamp":1786991099068,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-Al132374"],"award-info":[{"award-number":["R01-Al132374"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Government of Singapore Ministry of Education","doi-asserted-by":"publisher","award":["A-0008367-00-00"],"award-info":[{"award-number":["A-0008367-00-00"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.isci.2025.112915","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:50:41Z","timestamp":1750261841000},"page":"112915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquiline"],"prefix":"10.1016","volume":"28","author":[{"given":"Zheng Yen","family":"Phua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric Cheng Sheng","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Jie","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Yi Kang","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos Shi Ying","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jickky Palmae","family":"Sarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Cher","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Lin","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Keung","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-9492","authenticated-orcid":false,"given":"Yulin","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112915_bib1","series-title":"Global Tuberculosis Report","year":"2022"},{"key":"10.1016\/j.isci.2025.112915_bib2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.112915_bib3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2025.112915_bib4","series-title":"Global Tuberculosis Programme","article-title":"Shorter and more effective treatment for all people suffering from drug resistant TB","year":"2023"},{"key":"10.1016\/j.isci.2025.112915_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.112915_bib6","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa2033400","article-title":"Four-month rifapentine regimens with or without moxifloxacin","volume":"384","author":"Dorman","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.112915_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41573-024-00897-5","article-title":"Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease","volume":"23","author":"Dartois","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.112915_bib8","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.bmcl.2014.05.022","article-title":"Synthesis of new verapamil analogues and their evaluation in combination with rifampicin against Mycobacterium tuberculosis and molecular docking studies in the binding site of efflux protein Rv1258c","volume":"24","author":"Singh","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.isci.2025.112915_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2474","article-title":"Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections","volume":"9","author":"Hurdle","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.112915_bib10","doi-asserted-by":"crossref","first-page":"e7073","DOI":"10.1073\/pnas.1521988112","article-title":"Antiinfectives targeting enzymes and proton motive force","volume":"112","author":"Feng","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112915_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.isci.2025.112915_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00277157","article-title":"Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus","volume":"183","author":"Fischer","year":"1994","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.isci.2025.112915_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0140-6736(97)80051-7","article-title":"Peptide antibiotics","volume":"349","author":"Hancock","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2025.112915_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02107-17","article-title":"Verapamil targets membrane energetics in Mycobacterium tuberculosis, Antimicrob","volume":"62","author":"Chen","year":"2018","journal-title":"Agents Chemother."},{"key":"10.1016\/j.isci.2025.112915_bib15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/AAC.01462-13","article-title":"Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis, Antimicrob","volume":"58","author":"Gupta","year":"2018","journal-title":"Agents Chemother."},{"key":"10.1016\/j.isci.2025.112915_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.980844","article-title":"Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis","volume":"12","author":"McNeil","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.isci.2025.112915_bib17","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215512120","article-title":"The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance","volume":"120","author":"Lake","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112915_bib18","series-title":"The Handbook of Medicinal Chemistry","first-page":"1","article-title":"Physicochemical properties and compound quality","author":"Gleeson","year":"2015"},{"key":"10.1016\/j.isci.2025.112915_bib19","series-title":"The Practice of Medicinal Chemistry","first-page":"273","article-title":"Primary exploration of structure-activity relationships","author":"Wermuth","year":"2008"},{"key":"10.1016\/j.isci.2025.112915_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.tube.2010.09.002","article-title":"Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors","volume":"90","author":"Altaf","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.isci.2025.112915_bib21","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1021\/acs.chemrev.7b00602","article-title":"Hit generation in TB drug discovery: From genome to granuloma","volume":"118","author":"Yuan","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.isci.2025.112915_bib22","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1073\/pnas.052548299","article-title":"A new evolutionary scenario for the Mycobacterium tuberculosis complex","volume":"99","author":"Brosch","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112915_bib23","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1073\/pnas.1130426100","article-title":"The complete genome sequence of Mycobacterium bovis","volume":"100","author":"Garnier","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112915_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0027-2018","article-title":"Unraveling the structure of the mycobacterial envelope","volume":"7","author":"Daffe","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2025.112915_bib25","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1021\/acs.jmedchem.2c00227","article-title":"Tuberculosis drug discovery: Challenges and new horizons","volume":"65","author":"Fernandes","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2025.112915_bib26","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/acs.jmedchem.6b01530","article-title":"Amphiphilic indole derivatives as antimycobacterial agents: Structure\u2212activity relationships and membrane targeting properties","volume":"60","author":"Yang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2025.112915_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00517988","article-title":"Investigations on the structure-activity relationships of verapamil","volume":"302","author":"Mannhold","year":"1978","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.isci.2025.112915_bib28","series-title":"Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes","author":"Woods","year":"2011"},{"key":"10.1016\/j.isci.2025.112915_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ncomms1060","article-title":"A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy","volume":"1","author":"Pethe","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112915_bib30","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1099\/ijsem.0.001376","article-title":"Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp.abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov","volume":"66","author":"Tortoli","year":"2016","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/j.isci.2025.112915_bib31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.112915_bib32","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1021\/acs.jmedchem.8b00777","article-title":"Indolyl azaspiroketal Mannich bases are potent antimycobacterial agents with selective membrane permeabilizing effects and in vivo activity","volume":"61","author":"Nyantakyi","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2025.112915_bib33","doi-asserted-by":"crossref","first-page":"15991","DOI":"10.1021\/acs.jmedchem.1c01383","article-title":"Functionalized dioxonaphthoimidazoliums: A redox cycling chemotype with potent bactericidal activities against Mycobacterium tuberculosis","volume":"64","author":"Fridianto","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2025.112915_bib34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/jac\/46.6.917","article-title":"Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG","volume":"46","author":"Murugasu-Oei","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2025.112915_bib35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jac\/dku457","article-title":"Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents","volume":"70","author":"Lakshminarayana","year":"2015","journal-title":"J. Antimicrob."},{"key":"10.1016\/j.isci.2025.112915_bib36","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/acsmedchemlett.7b00287","article-title":"Indolylalkyltriphenyl-phosphonium analogues are membrane-depolarizing mycobacterial agents","volume":"8","author":"Li","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.isci.2025.112915_bib37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/mmi.13037","article-title":"The Psp system of Mycobacterium tuberculosis integrates envelope stress sensing and envelope preserving functions","volume":"97","author":"Datta","year":"2015","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.isci.2025.112915_bib38","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1021\/acsinfecdis.0c00121","article-title":"Potency increase of spiroketal analogs of membrane inserting indolyl Mannich base antimycobacterials is due to acquisition of MmpL3 inhibition","volume":"6","author":"Li","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.isci.2025.112915_bib39","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1073\/pnas.1700062114","article-title":"MmpL3 is the flippase for mycolic acids in mycobacteria","volume":"114","author":"Xu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112915_bib40","doi-asserted-by":"crossref","first-page":"40174","DOI":"10.1074\/jbc.M406796200","article-title":"The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism","volume":"279","author":"Boshoff","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.112915_bib41","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41598-018-38064-7","article-title":"2-Aminothiazoles collapse mycobacterial proton motive force and block the electron transport chain","volume":"9","author":"Joen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.112915_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12393","article-title":"Turning the respiratory flexibility of Mycobacterium tuberculosis against itself","volume":"7","author":"Lamprecht","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112915_bib43","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3389\/fmicb.2018.01898","article-title":"Mycobacterial cell wall synthesis inhibitors cause lethal ATP burst","volume":"9","author":"Shetty","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2025.112915_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0014-2016","article-title":"Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions","volume":"5","author":"Cook","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2025.112915_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01841-18","article-title":"Isoniazid bactericidal activity involves electron transport chain perturbation","volume":"63","author":"Zeng","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.112915_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fcimb.2016.00145","article-title":"Imaging the NADH:NAD+ homeostasis for understanding the metabolic response of mycobacterium to physiologically relevant stresses","volume":"6","author":"Bhat","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.isci.2025.112915_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2025.112915_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01540-19","article-title":"TBAJ-876 displays bedaquiline-like mycobactericidal potency without retaining the parental drug\u2019s uncoupler activity","volume":"64","author":"Sarathy","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.112915_bib49","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/ncomms4369","article-title":"Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism","volume":"5","author":"Koul","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112915_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02404-19","article-title":"TBAJ-876, a 3,5-dialkoxypyridine analogue of Bedaquiline, is active against Mycobacterium abscessus","volume":"64","author":"Sarathy","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.112915_bib51","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2025.112915_bib52","doi-asserted-by":"crossref","first-page":"14972","DOI":"10.1074\/jbc.M100407200","article-title":"Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil","volume":"276","author":"Loo","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.112915_bib53","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.1038\/ncomms8995","article-title":"Structural basis for the blockade of MATE multidrug efflux pumps","volume":"6","author":"Radchenko","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112915_bib54","article-title":"Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to increase bedaquiline activity","volume":"122","author":"Fountain","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112915_bib55","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/rccm.201304-0650OC","article-title":"Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor","volume":"188","author":"Gupta","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2025.112915_bib56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-pharmtox-010617-052438","article-title":"The role of efflux pumps in tuberculosis treatment and their promise as a target in drug development: Unraveling the black box","volume":"58","author":"te Brake","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225011769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225011769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:02:32Z","timestamp":1777946552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225011769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2589004225011769"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112915","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquiline","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112915"}}